Antibiotic Susceptibility of Bacteria Isolated from Open Fracture Grade III Presenting to Dr. Soetomo General Academic Hospital Surabaya
Downloads
Background: Open fractures are a typical case in the orthopedics field. Infection in an open fracture can cause osteomyelitis. An antibiotic susceptibility testing of patient specimen bacteria with open fractures aimed to determine suitable antibiotic agents with which to treat the infectious diseases caused by these bacteria.
Methods: This research is a descriptive study to assess antibiotic susceptibility in cases of open fracture grade III in Dr. Soetomo General Academic Hospital, Surabaya. Total sampling was performed on the microbiological culture results of patients diagnosed with open fracture grade III after debridement from October 2018 to September 2019. The identification of the microbes was based on Gram-positive and Gram-negative categories, and the classification was based on susceptibility to antibiotics, whether sensitive, intermediate, and resistant.
Results: The examination of the data from the microbiological culture results of patients with a diagnosis of open fracture grade III after debridement from October 2018 to September 2019 in Dr. Soetomo General Hospital Surabaya resulted in 56 research subjects who met the criteria. Acinetobacter baumannii was the most common bacterial species found in the microbiological examination of patients with open fractures, at 15.84%. Cefazoline and ceftriaxone showed low susceptibility. Levofloxacin showed a relatively good value of susceptibility against both Gram-positive and negative bacterial groups.
Conclusion: The antibiotic susceptibility pattern of bacteria from specimens in open fracture grade III patients in Dr. Soetomo General Academic Hospital Surabaya varies between each species of bacteria isolate.
Rubel IF and Lager S. The Socio-economic impact of chronic osteomyelitis: The most frequent complication. Orthop Procs 2004;86-B(SUPP_III):326.
Merritt K. Factors increasing the risk of infection in patients with open fractures. J Trauma Inj Infect Crit Care 1988;28(6):823-7.
Okike K and Bhattacharyya T. Trends in the management of open fractures: A critical analysis. J Bone Jt Surg - Ser A 2006;88(12):2739-48.
Ahmend I, Zafar H, Lakhnana NK, Ishtiaq S. Hospital antibiogram : A necessity in monitoring sensitivity of isolates and rationale use of antibiotic. Microbiol Res J Int 2016;13(3):1-8.
Sisay M, Worku T, Edessa D. Microbial epidemiology and antimicrobial resistance patterns of wound infection in Ethiopia: A meta-analysis of laboratory-based cross-sectional studies. BMC Pharmacol Toxicol 2019;20(1):1-19.
Smaill F. Antibiotic susceptibility and resistance testing: An overview. Can J Gastroenterol 2000;14(10):871-5.
Blom AW, Warwick D, Whitehouse MR. Apley and Solomon’s system of orthopaedics and trauma. 10th ed. United Kingdom: Bristol Medical School, 2018.
Arti HR. Comparison of early versus delayed debridement in open fractures. Pakistan J Med Sci 2012;28(5):856-9.
Court-brown CM, Bugler KE, Clement ND, Duckworth AD, Mcqueen MM. The epidemiology of open fractures in adults . A 15-year review. Injury 2012;43(6):891-7.
Odatuwa-Omagbemi DO. Open fractures: Epidemiological pattern, initial management and challenges in a sub-urban teaching hospital in Nigeria. Pan Afr Med J 2019;33:1-8.
Kale AR, Sonawane CS, Waghmare VU, Kalambe H. Open fractures and incidence of infection in tertiary care government hospital. Int J Sci Study 2017;5(403):24-8.
Zhu H, Li X, Zheng X. A descriptive study of open fractures contaminated by seawater: Infection, pathogens, and antibiotic resistance. Biomed Res Int 2017;2017.
Neidell MJ, Cohen B, Furuya Y, et al. Costs of healthcare- and community- associated infections with antimicrobial- resistant versus antimicrobial-susceptible organisms. Clin Infect Dis 2012;55:807-15.
Lautenbach E, Synnestvedt M, Weiner MG, et al. Epidemiology and impact of imipenem resistance in Acinetobacter baumannii. Infect Control Hosp Epidemiol 2014;30(12):1186-92.
Hsueh P, Teng L, Chen C, Chen W. Pandrug-Resistant Acinetobacter baumannii causing Nosocomial Infections in a University Hospital, Taiwan. Emerg Infect Dis 2002;8(8):827-32.
Paterson DL. The Epidemiological profile of infections with multidrug-resistant Pseudomonas aeruginosa and Acinetobacter species. Clin Infect Dis 2006;43(Suppl 2):43-8.
Fishbain J and Peleg AY. Treatment of Acinetobacter Infections. Clin Infect Dis 2010;51(1):79-84.
Jang J, Hur HG, Sadowsky MJ, Byappanahalli MN, Yan T, Ishii S. Environmental Escherichia coli: ecology and public health implications—a review. J Appl Microbiol 2017;123(3):570-81.
Abraham Y and Wamisho BL. Microbial susceptibility of bacteria isolated from open fracture wounds presenting to the err of black-lion hospital, Addis Ababa University, Ethiopia. African J Microbiol Res 2009;3(12):939-51.
Karageorgopoulos DE and Falagas ME. Current control and treatment of multidrug-resistant Acinetobacter baumannii infections. Lancet Infect Dis 2019;8(12):751-62.
Yang L, Jelsbak L, Lykke R, Damkiær S, Workman CT, Holm M. Evolutionary dynamics of bacteria in a human host environment. Proc Natl Acad Sci USA 2011;108(18):7481-6.
Nseir S, Ader F, Lubret R, Marquette C. Pathophysiology of airway colonization in critically ill COPD patients. Curr Drug Target 2011:514-20.
Fuentefria DB, Ferreira AE, Corção G. Antibiotic-resistant Pseudomonas aeruginosa from hospital wastewater and super fi cial water : Are they genetically related ? J Environ Manage 2011;92(1):250-5.
Giedrys-kalemba S. Phenotypic and genotypic characteristics of Pseudomonas aeruginosa strains isolated from hospitals in the north-west region of Poland. Pol J Microbiol 2006;55(2):103-12.
Bassetti M, Vena A, Croxatto A, Righi E, Guery B. How to manage Pseudomonas aeruginosa infections. Drugs Context 2018;7:1-18.
Shi HJ, Kim JH, Kim NY, Lee JB, Eom JS. Environmental culture of bacteria at the intensive care unit of a tertiary hospital in korea: a consideration for improving medical environmental safety and healthcare-associated infection. Korean J Heal assoc Infect Control Prev 2020;25(2):105-14.
Otchwemah R, Grams V, Tjardes T, Shafizadeh S, Bäthis H, Maegele M, et al. Bacterial contamination of open fractures - Pathogens, antibiotic resistances and therapeutic regimes in four hospitals of the trauma network Cologne, Germany. Injury 2015;46:S104-8.
Gustilo RB, Mendoza RM, Williams DN. Problems in the management of type III (severe) open fractures. J Trauma Inj Infect Crit Care 1984;24(8):742-6.
Patanwala AE, Radosevich JJ, Meshay I, Naderi M, Culver MA, Lee YG, et al. Cefazolin monotherapy versus cefazolin plus aminoglycosides for antimicrobial prophylaxis of type III open fractures. Am J Ther 2019;28(3):e284-91.
Copyright (c) 2021 JOINTS (Journal Orthopaedi and Traumatology Surabaya)
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
- The author acknowledges that the copyright of the article is transferred to the Journal of Orthopaedi and Traumatology Surabaya (JOINTS), whilst the author retains the moral right to the publication.
- The legal formal aspect of journal publication accessibility refers to Creative Commons Attribution-Non Commercial-Share Alike 4.0 International License (CC BY-NC-SA).
- All published manuscripts, whether in print or electronic form, are open access for educational, research, library purposes, and non-commercial uses. In addition to the aims mentioned above, the editorial board is not liable for any potential violations of copyright laws.
- The form to submit the manuscript's authenticity and copyright statement can be downloaded here.
Journal of Orthopaedi and Traumatology Surabaya (JOINTS) is licensed under a Creative Commons Attribution-Non Commercial-Share Alike 4.0 International License.
Journal Orthopaedi and Traumatology Surabaya (JOINTS) (